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Background
Paracetamol is a widely used analgesic and antipyretic
drug. HS (hypersensitivity reactions) to paracetamol are
rare but appear to be increasing. Our aim was to char-
acterize a series of patients with suspected PHS (parace-
tamol HS).
Methods
A total of 245 patients with suspected NSAIDs HS were
referred to our Drug Allergy Clinic from 2009 to 2013
and those with suspected PHS were evaluated. Demo-
graphic data, atopy, comorbidities, HS to other NSAIDs,
timing of reaction, clinical manifestations and diagnostic
procedures were assessed. PHS was confirmed by a posi-
tive DPT (drug provocation test) and considered prob-
able based only on a suggestive clinical history.
Results
Fifty patients (20.4%) had suspected PHS: 56% male,
median age 41.5 years [6-81]; 46% atopic; 18% had
chronic urticaria and/or angioedema, 18% had asthma
and rhinitis and 16% had rhinitis/rhinoconjunctivitis.
Thirty seven patients (74%) had suspected HS to multiple
NSAIDs and 38% to other drugs, mostly antibiotics.
Cutaneous reactions were reported by 60% of the sub-
jects, both cutaneous and respiratory symptoms by 24%,
anaphylaxis by 10% and isolated respiratory symptoms by
6%. Thirty one (62%) reported IR (immediate reactions),
32% DR (delayed reactions) and 6% were unable to recall
the onset of the reaction. SPT and IDT were negative in
all patients tested (17 out of 31 with IR; 1 out of 3 with
indeterminate reaction); patch tests were negative in 9
out of 16 patients with DR. DPT with Paracetamol was
performed in 60% of the patients and was positive in 4 (3
out of 18 with IR; 1 out of 10 with DR). Long term chal-
lenge was negative in 10 patients (9 with DR and negative
DPT; 1 with indeterminate reaction and negative DPT).
PHS was confirmed in 4 (8%) patients, excluded in
32 (64%) and considered probable in 4 (8%). The study
was inconclusive in 10 (20%) because patients refused
DPT or missed the scheduled appointments. It was possi-
ble to confirm HS to other NSAIDs in 1 patient with
confirmed PH and in 3 patients in whom PHS was
excluded. HS to other NSAIDs was considered probable
in 2 patients with confirmed PHS and in 12 patients with
excluded PHS.
Conclusion
As previously described in the literature, our study sug-
gests that PHS is rare and usually presents with cutaneous
symptoms. We observed a predominance of male gender,
unlike published reports on NSAIDs HS. Although nega-
tive, skin tests did not exclude PHS and DPT remains the
gold standard for PHS diagnosis.
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